Search - tctmd.com

Displaying 121 - 140 of 469

Sort: Relevancy | Date

Presentation TCT 2017

Debate: Making the Case for Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors!

Presenter: John A. Bittl, Freek W.A. Verheugt, Dimitrios Alexopoulos

October 30, 2017

Presentation TCT 2017

NSTEMI Case Presentation: Why the DAPT Pre-load Decision Matters

Presenter: John A. Bittl, Freek W.A. Verheugt, Patricia J. Best

October 30, 2017

Presentation TCT 2017

Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy

Presenter: Thomas H. Maloney, C. Michael Gibson

October 30, 2017

Presentation TCT 2017

Case Resolution: STEMI/ACS

Presenter: Thomas H. Maloney, Jaya Chandrasekhar

October 30, 2017

Presentation TCT 2017

Should Choice of Parenteral Therapy for Primary PCI in STEMI Depend on Vascular Access?

Presenter: Michael S. Lee, Dirk Sibbing, John A. Bittl

October 30, 2017

Presentation TCT 2017

Case Presentation Introduction: STEMI/ACS

Presenter: Thomas H. Maloney, Jaya Chandrasekhar

October 30, 2017

Presentation TCT 2017

Parenteral Therapy in STEMI: Does VALIDATE Change the Equation?

Presenter: Michael S. Lee, Dirk Sibbing, David Erlinge

October 30, 2017

Presentation TCT 2017

What Is the Next Quality Indicator to Improve Outcomes in STEMI?

Presenter: Thomas H. Maloney, Connie N. Hess

October 30, 2017

Presentation TCT 2017

Case Resolution: STEMI, Cardiogenic Shock, and Cardiac Arrest How We Treated

Presenter: Sripal Bangalore, Manesh R. Patel, Navin K. Kapur

October 30, 2017

Presentation TCT 2017

Why I Use Cangrelor for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Dmitriy N. Feldman

October 30, 2017

Presentation TCT 2017

Why I Prefer Bivalirudin for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Uwe Zeymer

October 30, 2017

Presentation TCT 2017

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Gregory J. Dehmer

October 30, 2017

Presentation TCT 2017

Why I Prefer a Heparin Plus a GPI for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Eric R. Bates

October 30, 2017

$Why I Prefer Unfractionated Heparin Without GPI for Primary PCI in STEMI!$

Presentation TCT 2017

Why I Prefer Unfractionated Heparin Without GPI for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, A. Michael Lincoff

October 30, 2017

Presentation TCT 2017

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Holger Thiele

October 30, 2017

Presentation TCT 2017

Case Introduction: A Patient With STEMI, Cardiogenic Shock, and Cardiac Arrest How Should We Treat?

Presenter: Sripal Bangalore, Manesh R. Patel, Navin K. Kapur

October 30, 2017

Presentation TCT 2017

STEMI Case Presentation: Why the Choice of Patental Therapy Matters

Presenter: Michael S. Lee, Dirk Sibbing, Francesco Franchi

October 30, 2017

Presentation TCT 2017

Case Resolution: STEMI With Multivessel Disease How We Treated

Presenter: Sripal Bangalore, Anthony H. Gershlick, Prashant Kaul

October 30, 2017

Presentation TCT 2017

STEMI/ACS With Multivessel Disease: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Jacqueline E. Tamis-Holland

October 30, 2017

Presentation TCT 2017

STEMI/ACS With Multivessel Disease: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Stefan K. James

October 30, 2017

Advertisement

Debate: Making the Case for Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors!

NSTEMI Case Presentation: Why the DAPT Pre-load Decision Matters

Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy

Case Resolution: STEMI/ACS

Should Choice of Parenteral Therapy for Primary PCI in STEMI Depend on Vascular Access?

Case Presentation Introduction: STEMI/ACS

Parenteral Therapy in STEMI: Does VALIDATE Change the Equation?

What Is the Next Quality Indicator to Improve Outcomes in STEMI?

Case Resolution: STEMI, Cardiogenic Shock, and Cardiac Arrest How We Treated

Why I Use Cangrelor for Primary PCI in STEMI!

Why I Prefer Bivalirudin for Primary PCI in STEMI!

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the US Guidelines and AUC Say?

Why I Prefer a Heparin Plus a GPI for Primary PCI in STEMI!

Why I Prefer Unfractionated Heparin Without GPI for Primary PCI in STEMI!

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the Data and EU Guidelines Say?

Case Introduction: A Patient With STEMI, Cardiogenic Shock, and Cardiac Arrest How Should We Treat?

STEMI Case Presentation: Why the Choice of Patental Therapy Matters

Case Resolution: STEMI With Multivessel Disease How We Treated

STEMI/ACS With Multivessel Disease: What Do the US Guidelines and AUC Say?

STEMI/ACS With Multivessel Disease: What Do the Data and EU Guidelines Say?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content